Isoform-specific ras functions in development and cancer

被引:86
作者
Quinlan, Margaret P. [1 ]
Settleman, Jeffrey [1 ]
机构
[1] Harvard Univ, Ctr Canc, Massachusetts Gen Hosp, Sch Med, Charlestown, MA 02129 USA
关键词
cancer; development; GTPases; Ras; stem cells; K-RAS; PLASMA-MEMBRANE; H-RAS; GERMLINE MUTATIONS; N-RAS; TUMOR PROGRESSION; COSTELLO-SYNDROME; NOONAN-SYNDROME; KRAS MUTATIONS; ONCOGENIC RAS;
D O I
10.2217/14796694.5.1.105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The three closely related mammalian ras genes, Was, Nras and Kras, have each been implicated in human tumorigenesis by virtue of mutational activation. However, while these genes encode proteins with very similar biochemical properties, activating ras alleles corresponding to the various isoforms have been linked to particular malignancies. Accumulating evidence suggests that these proteins exert distinct activities in a tissue-specific context, apparently reflecting developmental lineage-specific roles for the various ras isoforms, Some of these distinct functions appear to reflect differences in their C-termini, which determine distinct subcellular localization, thereby suggesting a role for compartmentalized signaling, In this review, we discuss the biological functions of the ras isoforms in the context of tissue-specific function as it relates to ras function in development and human cancer.
引用
收藏
页码:105 / 116
页数:12
相关论文
共 81 条
[1]   Blocking oncogenic Ras signaling for cancer therapy [J].
Adjei, AA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) :1062-1074
[2]   Germline mutations in HRAS proto-oncogene cause Costello syndrome [J].
Aoki, Y ;
Niihori, T ;
Kawame, H ;
Kurosawa, K ;
Filocamo, M ;
Kato, K ;
Suzuki, Y ;
Kure, S ;
Matsubara, Y .
NATURE GENETICS, 2005, 37 (10) :1038-1040
[3]   The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders [J].
Aoki, Yoko ;
Niihori, Tetsuya ;
Narumi, Yoko ;
Kure, Shigeo ;
Matsubara, Yoichi .
HUMAN MUTATION, 2008, 29 (08) :992-1006
[4]   H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway [J].
Apolloni, A ;
Prior, IA ;
Lindsay, M ;
Parton, RG ;
Hancock, JF .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (07) :2475-2487
[5]   MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION [J].
BARSAGI, D ;
FERAMISCO, JR .
CELL, 1985, 42 (03) :841-848
[6]  
BAUER J, 2006, J INVEST DERMATOL
[7]   DIFFERENTIATION OF 3T3-L1 FIBROBLASTS TO ADIPOCYTES INDUCED BY TRANSFECTION OF RAS ONCOGENES [J].
BENITO, M ;
PORRAS, A ;
NEBREDA, AR ;
SANTOS, E .
SCIENCE, 1991, 253 (5019) :565-568
[8]   Stops along the RAS pathway in human genetic disease [J].
Bentires-Alj, M ;
Kontaridis, MI ;
Neel, BG .
NATURE MEDICINE, 2006, 12 (03) :283-285
[9]  
BERTHIAUME LG, 2002, SCI STKE, V152, pPE41
[10]   PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis [J].
Bivona, TG ;
Quatela, SE ;
Bodemann, BO ;
Ahearn, IM ;
Soskis, MJ ;
Mor, A ;
Miura, J ;
Wiener, HH ;
Wright, L ;
Saba, SG ;
Yim, D ;
Fein, A ;
Perez de Castro, I ;
Li, C ;
Thompson, CB ;
Cox, AD ;
Philips, MR .
MOLECULAR CELL, 2006, 21 (04) :481-493